Cited by 17Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and OutcomesSchizophrenia research and treatment

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Brain Anatomical Alterations in Young Cannabis Users: Is it All Hype? A Meta-Analysis of Structural Neuroimaging Studies

Open access

Abstract

Introduction: Cannabis use has a high prevalence in young youth and is associated with poor psychosocial outcomes. Such outcomes have been ascribed to the impact of cannabis exposure on the developing brain. However, findings from individual studies of volumetry in youth cannabis users are equivocal. Objectives: Our primary objective was to systematically review the evidence on brain volume differences between young cannabis users and nonusers aged 12–26 where profound neuromaturation occurs, accounting for the role of global brain volumes (GBVs). Our secondary objective was to systematically integrate the findings on the association between youth age and volumetry in youth cannabis users. Finally, we aimed to evaluate the quality of the evidence. Materials and Methods: A systematic search was run in three databases (PubMed, Scopus, and PsycINFO) and was reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We run meta-analyses (with and without controlling for GBV) of brain volume differences between young cannabis users and nonusers. We conducted metaregressions to explore the role of age on volumetric differences. Results: Sixteen studies were included. The reviewed samples included 830 people with mean age 22.5 years (range 14–26 years). Of these, 386 were cannabis users (with cannabis use onset at 15–19 years) and 444 were controls. We found no detectable group differences in any of the GBVs (intracranium, total brain, total white matter, and total gray matter) and regional brain volumes (i.e., hippocampus, amygdala, orbitofrontal cortex, and total cerebellum). Age and cannabis use level did not predict (standardized mean) volume group differences in metaregression. We found little evidence of publication bias (Egger's test p >0.1). Conclusions: Contrary to evidence in adult samples (or in samples mixing adults and youth), previous single studies in young cannabis users, and meta-analyses of brain function in young cannabis users, this early evidence suggests nonsignificant volume differences between young cannabis users and nonusers. While prolonged and long-term exposure to heavy cannabis use may be required to detect gross volume alterations, more studies in young cannabis users are needed to map in detail cannabis-related neuroanatomical changes.

Overview

Integrity signals

Registry

Crossref · 10.1089/can.2021.0099

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • These alterations were more consistently observed in persons with a history of chronic cannabis use.

    “These alterations were more consistently observed in persons with a history of chronic cannabis use [76].”
  • A recent meta-analysis of 16 studies found no evidence of differences in global brain volume between cannabis users and non-users aged 12-16.

    “A recent meta-analysis of 16 studies that examined global brain volume (GBV) of 12–16 year-olds found no evidence of differences in GBV between cannabis users and non-users [154].”

    From Consequences of adolescent drug use (2023) · cites this paper as [154]

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 64

  1. 10.1007/s00406-018-0976-1 · DOI
  2. 10.1016/j.biopsych.2015.07.028 · DOI · Paper page
  3. 10.1021/ja01092a065 · DOI
  4. 10.1007/s00221-012-3186-5 · DOI
  5. 10.1016/j.phrs.2016.07.008 · DOI · Paper page
  6. 10.1016/j.jchemneu.2021.101943 · DOI
  7. 10.1038/npp.2017.143 · DOI
  8. 10.1523/JNEUROSCI.1165-19.2019 · DOI · Paper page
  9. 10.1111/j.1369-1600.2008.00110.x · DOI
  10. 10.3389/fpsyt.2020.00859 · DOI
  11. Chye Y, , Kirkham R, , Lorenzetti V, et al. Cannabis, cannabinoids, and brain morphology: a review of the evidence. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020; 6:627–635.
  12. 10.1007/s00406-019-00979-1 · DOI
  13. 10.1111/pcn.12085 · DOI
  14. 10.1016/j.neuroimage.2010.06.025 · DOI
  15. 10.3174/ajnr.A4299 · DOI
  16. 10.1038/s41386-019-0347-2 · DOI
  17. 10.1016/j.drugalcdep.2018.02.007 · DOI
  18. Lorenzetti V. The impact of regular cannabis use on human brain structure page 117 [PhD Thesis]. The University of Melbourne Australia 2012.
  19. 10.3389/fpsyg.2010.00225 · DOI · Paper page
  20. 10.1016/j.bbr.2011.05.031 · DOI
  21. 10.1111/j.1369-1600.2009.00166.x · DOI
  22. 10.1111/j.1469-7610.2007.01728.x · DOI
  23. 10.1016/j.ntt.2006.10.010 · DOI
  24. 10.1007/s00213-017-4606-9 · DOI
  25. 10.1111/adb.12652 · DOI
  26. 10.1016/j.pscychresns.2009.12.004 · DOI
  27. 10.1016/j.pscychresns.2019.04.011 · DOI
  28. 10.1002/hbm.22473 · DOI · Paper page
  29. 10.1136/bmj.315.7109.629 · DOI · Paper page
  30. 10.1016/j.jpsychires.2011.01.004 · DOI
  31. 10.1007/s00213-015-3931-0 · DOI
  32. Demirakca T, , Sartorius A, , Ende G, et al. Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol. Drug Alcohol Depend. 2011; 114:242–245.
  33. 10.1523/JNEUROSCI.2946-14.2015 · DOI
  34. 10.1371/journal.pone.0055821 · DOI
  35. 10.1007/s00406-019-00981-7 · DOI
  36. 10.1111/desc.12057 · DOI · Paper page
  37. 10.1002/hbm.23154 · DOI
  38. 10.3389/fncel.2018.00441 · DOI
  39. 10.1093/hmg/ddx139 · DOI
  40. 10.1038/tp.2015.201 · DOI
  41. 10.1517/14728221003709792 · DOI
  42. 10.2174/138161208785740117 · DOI
  43. Lara-Celador I, , Goñi-de-Cerio F, , Alvarez A, et al. Using the endocannabinoid system as a neuroprotective strategy in perinatal hypoxic-ischemic brain injury. Neural Regen Res. 2013; 8:731–744.
  44. 10.1177/155005940904000110 · DOI · Paper page
  45. 10.1177/0004867419859077 · DOI
  46. 10.1007/s11481-018-9782-9 · DOI
  47. 10.1001/archpsyc.65.6.694 · DOI
  48. 10.1523/JNEUROSCI.3375-17.2018 · DOI
  49. 10.1111/add.14842 · DOI
  50. 10.1111/add.15107 · DOI
  51. 10.1016/j.dcn.2017.11.008 · DOI
  52. 10.1111/adb.12830 · DOI
  53. 10.1038/13158 · DOI · Paper page
  54. Schmid CH Stijnen T White I. Handbook of meta-analysis. CRC Press: Boca Raton 2020. · DOI
  55. Sobell LC Sobell MB. Timeline follow-back. In: Litten RZ Allen JP eds. Measuring alcohol consumption: psychosocial and biochemical methods. Humana Press: Totowa NJ 1992. · DOI · Paper page
  56. 10.1016/j.drugalcdep.2010.02.017 · DOI
  57. 10.1007/s00406-019-00983-5 · DOI
  58. 10.1016/j.biopsych.2016.01.004 · DOI
  59. 10.1016/S0140-6736(19)31789-1 · DOI · Paper page
  60. 10.1111/j.1476-5381.2011.01280.x · DOI
  61. 10.1016/0091-3057(91)90380-K · DOI
  62. 10.1016/S2215-0366(20)30074-2 · DOI
  63. 10.1016/S0140-6736(07)61162-3 · DOI · Paper page
  64. 10.1016/j.neubiorev.2016.03.010 · DOI

Cited by

Sorted by citations

Metadata

Authors
Lorenzetti, V., Kowalczyk, M., Duehlmeyer, L., Greenwood, L.-M., Chye, Y., Yücel, M., Whittle, S., & Roberts, C. A.
Affiliations
  • Australian Catholic University (AU)
  • Australian National University (AU)
  • BrainPark, The Turner Institute for Brain and Mental Health, School of Psychological Sciences and Monash Biomedical Imaging Facility, Clayton, Australia.
  • The University of Melbourne (AU)
  • University of Liverpool (GB)
Corresponding author
Lorenzetti, Valentina
Venue
Cannabis & Cannabinoid Research
Published
2023-02-01
Volume
8
Issue
1
Pages
184-196
ISSN
  • 2378-8763 (ISSN-L)
  • 2578-5125
OpenAlex
W4224219395
Cited by
17
References
9
Citations by year
2026: 1 · 2025: 6 · 2024: 7 · 2023: 2
FWCI
0.57
Type
journal article
Language
en
Open access
Locations
  • Cannabis and Cannabinoid Research (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Figshare (submittedVersion, cc-by)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
cannabis use, brain volume, regional brain volume, hippocampus, amygdala, orbitofrontal cortex, cerebellum, white matter, gray matter, brain development, neuroanatomical changes
MeSH terms
Adolescent, Adult, Brain, Cannabis, Humans, Magnetic Resonance Imaging, Young Adult, Neuroimaging, Gray Matter

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review